Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2000. Start Trial.
Date Value
September 30, 2026 49.90%
August 31, 2026 49.90%
July 31, 2026 49.90%
June 30, 2026 49.90%
May 31, 2026 49.90%
April 30, 2026 49.90%
March 31, 2026 49.90%
February 28, 2026 49.90%
January 31, 2026 49.90%
December 31, 2025 49.90%
November 30, 2025 49.90%
October 31, 2025 49.90%
September 30, 2025 49.90%
August 31, 2025 49.90%
July 31, 2025 49.90%
June 30, 2025 49.90%
May 31, 2025 49.90%
April 30, 2025 49.90%
March 31, 2025 49.90%
February 28, 2025 49.90%
January 31, 2025 49.90%
December 31, 2024 49.90%
November 30, 2024 49.90%
October 31, 2024 49.90%
September 30, 2024 49.90%
Date Value
August 31, 2024 49.90%
July 31, 2024 49.90%
June 30, 2024 49.90%
May 31, 2024 49.90%
April 30, 2024 49.90%
March 31, 2024 49.90%
February 29, 2024 49.90%
January 31, 2024 49.90%
December 31, 2023 49.90%
November 30, 2023 49.90%
October 31, 2023 49.90%
September 30, 2023 49.90%
August 31, 2023 49.90%
July 31, 2023 49.90%
June 30, 2023 49.90%
May 31, 2023 49.90%
April 30, 2023 49.90%
March 31, 2023 49.90%
February 28, 2023 49.90%
January 31, 2023 49.90%
December 31, 2022 49.90%
November 30, 2022 49.90%
October 31, 2022 49.90%
September 30, 2022 49.00%
August 31, 2022 47.81%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Stryker Corp. 32.46%
Zimmer Biomet Holdings, Inc. 51.64%
Abbott Laboratories 39.63%
Boston Scientific Corp. 60.58%
Globus Medical, Inc. 47.91%